Effects of danshen on the pharmacokinetics of rosuvastatin

Effects of danshen on the pharmacokinetics of rosuvastatin - Danshen effects on Pharmacokinetics of rosuvastatin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028112

Enrollment

Registered

2017-07-06

Start date

2017-07-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

sigle oral dose of rosuvastatin 5 mg with placebo single oral dose of rosuvastatin 5mg with danshen formula 2.5g

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: healthy male volunteer

Exclusion criteria

Exclusion criteria: volunteer with history of psychiatric disorder and alcohol poisoning, cigarette smoker

Design outcomes

Primary

Measure	Time frame
change in pharmacokinetics	—

Countries

Japan

Contacts

Public ContactJunichi Hasegawa

Tottori University Faculty of Medicine Pharmacotherapeutics

hasegawa@med.tottori-u.ac.jp0859-38-6171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026